- The Moderna COVID‑19 Vaccine has not been approved or licensed by the US Food and Drug Administration (FDA), but has been authorized for emergency use by FDA, under an Emergency Use Authorization (EUA), to prevent Coronavirus Disease 2019 (COVID‑19) for use in individuals 18 years of age and older.
- The EUA for the Moderna COVID‑19 Vaccine is in effect for the duration of the COVID‑19 EUA declaration justifying emergency use of the product, unless the declaration is terminated or the authorization is revoked sooner.
When Are My Patients Eligible for a Booster?
A single Moderna COVID‑19 Vaccine booster dose (0.25 mL) may be administered intramuscularly at least 6 months after completing a primary series of the Moderna COVID‑19 Vaccine to individuals:
- 65 years of age and older
- 18 through 64 years of age at high risk of severe COVID‑19
- 18 through 64 years of age with frequent institutional or occupational exposure to SARS‑CoV‑2
A single booster dose of the Moderna COVID‑19 Vaccine (0.25 mL) may be administered as a heterologous booster dose following completion of primary vaccination with another authorized or approved COVID‑19 vaccine. The eligible population(s) and dosing interval for the heterologous booster dose are the same as those authorized for a booster dose of the vaccine used for primary vaccination.
The most current information on booster dose eligibility criteria is available from the US Centers for Disease Control and Prevention (CDC).
Where Is the Vaccine Available?
Moderna has been contracted by the United States Government to provide the Moderna COVID‑19 Vaccine under the EUA. For details on vaccine distribution, including where and how much vaccine is supplied, you should contact your state, territorial, tribal or local health department.
How Can My Practice Get the Vaccine?
For details on vaccine distribution, including getting vaccine for your practice, you should contact your state, territorial, tribal or local health department. More information on providing COVID‑19 vaccination at your practice is available from the US Centers for Disease Control and Prevention.